SCHEMBL4235362

SCHEMBL4235362

CCC(CC)NC(=O)N(N)c1ccc(Oc2ccc(N)c(OC)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 3/20 0.46
TAS1R1 Q7RTX1 3/20 0.46
ALDH1A1 P00352 2/20 0.40
CYP3A4 P08684 1/20 0.40
PKM P14618 1/20 0.39
KDM4E B2RXH2 1/20 0.37
RAB9A P51151 1/20 0.37
MMP2 P08253 1/20 0.35
ADAM17 P78536 1/20 0.35
HTT P42858 1/20 0.35
PTPN7 P35236 1/20 0.34
DUSP3 P51452 1/20 0.34
RAF1 P04049 1/20 0.34
ARAF P10398 1/20 0.34
BRAF P15056 1/20 0.34
HDAC1 Q13547 1/20 0.34
EGLN2 Q96KS0 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4235462 0.81 TAS1R3 (0.45) TAS1R3TAS1R1PKMKDM4ERAB9A
SCHEMBL4236682 0.81 PKM (0.64) TAS1R3TAS1R1ALDH1A1CYP3A4PKM
Ammonia Solution, Strong SCHEMBL4235357 0.80 PKM (0.63) TAS1R3TAS1R1ALDH1A1CYP3A4PKM
SCHEMBL4233433 0.77 TAS1R3 (0.41) TAS1R3TAS1R1PKMKDM4ERAB9A
SCHEMBL12593832 0.72 AAK1 (0.48) TAS1R3TAS1R1ALDH1A1CYP3A4RAF1
SCHEMBL272888 0.71 ALDH1A1 (0.76) ALDH1A1CYP3A4HTT
SCHEMBL4228568 0.69 MAPK1 (0.50) ALDH1A1CYP3A4PKMRAB9AMMP2
SCHEMBL23530432 0.69 ALDH1A1 (0.58) ALDH1A1CYP3A4RAB9AHTT
SCHEMBL30027797 0.69 ALDH1A1 (0.58) ALDH1A1CYP3A4RAB9AHTT
SCHEMBL4688156 0.69 BRAF (0.51) ALDH1A1CYP3A4RAB9AHTTRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233910-A1 Npy antagonists, preparation and uses CEREP (FR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233910-A1 Npy antagonists, preparation and uses NPY1R, NPY5R, NPY2R TAS1R3 1436/4885TAS1R1 1073/4885ALDH1A1 4542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.